3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
2
Active not recruiting
2
Unknown
1
Terminated
1
Suspended
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Polycystic Ovary Syndrome
1
Neoplasms
1
Glioblastoma
1
Interventions
Temozolomide
44
Radiotherapy
16
Bevacizumab
9
Surgical Procedures, Operative
5
Carmustine
5
pembrolizumab
4
Lomustine
4
Drug Therapy
4
Sunitinib
3
Standard of Care
3
Radiation
3
Procarbazine
3
Irinotecan
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Chlorotoxin
3
Carboplatin
3
Blood Specimen Collection
3
tislelizumab
2
fludarabine
2
camrelizumab
2
Radiosurgery
2
Neoadjuvant Therapy
2
Magnetic Resonance Spectroscopy
2
Hyperbaric Oxygenation
2
Ethanol
2
Cyclophosphamide
2
Chemotherapy, Adjuvant
2
CT-322
2
Bortezomib
2
Aminolevulinic Acid
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Glioblastoma
×
Diet, Ketogenic
×
Clear all
NCT02939378
2016-10-20
KGDinrGBM
Beijing Tiantan Hospital
Phase 1/2
Unknown
60 enrolled